Egyptian Liver Journal

Table 5 Correlation between duration of illness and PLT count and between FIB-4 and PLT count in the three treatment groups

From: Impact of different anti-HCV regimens on platelet count during treatment in Egyptian patients

Subgroup	Parameter		Platelet count decrement
Subgroup	Parameter		Week 2	Week 4	EOT
Group 1 Triple	Duration of illness	Correlation coefficient	.076	.117	.109
		p value	.578	.391	.424
		N	56
Group 2 SOF/RBV		Correlation coefficient	.063	.071	− .125
		p value	.649	.608	.364
		N	55
Group 3 SIM/SOF		Correlation coefficient	.129	.022	− .004
		p value	.338	.871	.974
		N	57	57	55
Group 1 Triple	FIB-4 calculation	Correlation coefficient	− .267	− .213	− .110
		p value	.047	.114	.418
		N	56
Group 2 SOF/RBV		Correlation coefficient	-.486	− .463	− .105
		p value	< 0.001	< 0.001	.445
		N	55
Group 3 SIM/SOF		Correlation coefficient	− .243	− .494	− .151
		p value	.069	< 0.001	.270
		N	57	57	55

Back to article page